The 100-day PSA: usefulness as surrogate end point for biochemical disease-free survival after definitive radiotherapy of prostate cancer-Reference-Cited by-同舟云学术

The 100-day PSA: usefulness as surrogate end point for biochemical disease-free survival after definitive radiotherapy of prostate cancer

Published:2004-08-03 Issue:3 Volume:7 Page:263-267
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Johnstone P A S,Williams S R,Riffenburgh R H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500736.pdf

Reference32 articles.

1. Powell C et al. Outcome for surgically staged localized prostate cancer treated with external beam radiation therapy. J Urol 1997; 157: 1754–1759.

2. Gray CL, Powell CR, Riffenburgh RH, Johnstone PAS . 20-year outcome for patients withT1–3N0 surgically staged prostate cancer treated with external beam radiation therapy. J Urol 2001; 166: 116–118.

3. Vollmer RT, Montana GS . The dynamics of prostate-specific antigen after definitive radiation therapy for prostate cancer. Clin Cancer Res 1999; 5: 4119–4125.

4. Johnstone PAS et al. How much do prostate specific antigen levels matter after 10 years? The fate of 10-year clinically recurrence-free survivors after definitive radiotherapy for T1–3N0M0 prostate cancer. Radiat Oncol Invest 1998; 6: 103–108.

5. Walsh PC . Editorial: Localized prostate cancer—mortality and morbidity. J Urol 1997; 157: 1773.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation;Health Technology Assessment;2010-10

2. A 3-D Mixed-Reality System for Stereoscopic Visualization of Medical Dataset;IEEE Transactions on Biomedical Engineering;2009-11

3. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer;Cancer;2007

4. Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death;Cancer;2007-01-01